OverviewChartTechnicalNewsTraderScreen

DBV Technologies SA/  US23306J1016  /

NASDAQ
2024-05-01  10:00:00 PM Chg. +0.0284 Volume Bid11:26:33 AM Ask11:26:33 AM High Low
0.6900USD +4.29% 14,880
Turnover: 9,557.4229		 0.6300Bid Size: 11,500 0.6850Ask Size: 1,000 0.6900 0.6515
GlobeNewswire 04-25 Combined General Meeting of May 16, 2024
GlobeNewswire 04-01 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 03-08 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Docu...
GlobeNewswire 03-07 DBV Technologies Reports Full Year 2023 Financial Results and Business Update
GlobeNewswire 03-04 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
GlobeNewswire 02-20 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
GlobeNewswire 01-16 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire 2023-11-09 DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE T...
GlobeNewswire 2023-11-02 DBV Technologies to Present New Data at ACAAI 2023
GlobeNewswire 2023-10-31 DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety...
GlobeNewswire 2023-10-27 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
GlobeNewswire 2023-10-16 DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
GlobeNewswire 2023-09-05 DBV Technologies to Participate in Upcoming Investor Conference
GlobeNewswire 2023-08-24 Elucida Oncology Appoints Ramzi Benamar as Chief Financial Officer
GlobeNewswire 2022-03-14 DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference
GlobeNewswire 2022-03-09 DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration...
GlobeNewswire 2022-03-03 DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
GlobeNewswire 2022-02-24 DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022
GlobeNewswire 2022-02-22 DBV Technologies to Participate in Upcoming AAAAI 2022 Congress
GlobeNewswire 2022-02-14 DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference
GlobeNewswire 2022-01-21 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire 2022-01-07 DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference
GlobeNewswire 2021-12-20 DBV Technologies Provides Update on Investigational Viaskin™ Peanut
GlobeNewswire 2021-11-24 DBV Technologies to Participate in an Upcoming Investor Conference
GlobeNewswire 2021-11-01 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies...